Tickertape - Financial freedom begins here

Larsen & Toubro (L&T) has secured a 'Baa1' long term issuer rating with a 'Stable' outlook from Moody's Ratings, reinforcing the Group's robust credit profile and financial resilience. The 'Baa1' rating signifies a quality investment-grade credit profile, reflecting strong capacity to meet financial commitments and a low level of credit risk. It also underscores L&T's prudent financial management and consistent operational performance. The 'Stable' outlook reflects expectations that L&T and its core international subsidiaries will maintain strict fiscal discipline, comfortable leverage levels and healthy operating margins as high-margin engineering services and large-scale EPC projects in West Asia continue to scale. Notably, this premium rating stands two notches above India's sovereign rating of 'Baa3', positioning L&T among an exclusive group of Indian multinational corporates evaluated stronger than the country's sovereign rating. Moody's, the global ratings major, has also assigned a matching 'Baa1' rating to L&T Hydrocarbon Saudi Company (a subsidiary of L&T), reflecting the business vertical's tight operational integration with the parent Company and the strategic importance of Larsen & Toubro's West Asia operations.

Kutch Copper (KCL), a subsidiary of Adani Enterprises (AEL), has earned London Metal Exchange (LME) certification for 'Adani Copper'. Approval by the world centre for the trading of industrial metals validates KCL's manufacturing excellence and responsible sourcing practices against strict global benchmarks, enabling Adani Copper cathodes to be delivered with warrants eligible for issuance against LME Copper futures contracts from 10 July 2026. For the Adani Group, LME listing of Adani Copper as a Good Delivery brand for 'Copper Grade A' contracts places the brand alongside the world's leading copper brands, conferring international recognition and market credibility on the Group's entry into the metals sector and its emergence as a globally competitive producer of refined copper. An LME-brand certification is a rigorous process involving superior quality assurances ' covering chemical composition, shape and weight ' alongside strict responsible sourcing protocols. The LME listing enables eligible Adani Copper cathodes to be placed on warrant in LME-approved warehouses, strengthening financing flexibility as LME-listed metal is recognised as high liquid asset that can be used as collateral. For the LME, the addition of Adani Copper broadens the exchange's deliverable base with high-quality cathode from a major new production hub, deepening the liquidity and geographic diversity of the global copper market.

Uno Minda announced a landmark strategic expansion into the Four-Wheeler (4W) Passenger Vehicle Seating Systems segment - one of the highest value product categories in the automotive supply chain. To support this new product line, the company's Board of Directors has approved the setting up of a state-of-the-art greenfield manufacturing facility in Chhatrapati Sambhajinagar (formerly Aurangabad), Maharashtra, with a proposed capital expenditure of approximately Rs 320 crore. The facility is expected to commence operations by Q4FY28. The project will be executed under Uno Minda Tachi-S Seating, a Joint Venture (JV) with TACHI-S Company, Japan, a leading global automotive seating manufacturer.

Orchid Pharma (Orchid) and Pharmasyntez JSC (Pharmasyntez) have entered into a licensing and supply agreement for Exblifep' (cefepime/enmetazobactam), a novel combination antibiotic for the treatment of complicated urinary tract infections (cUTI) and hospital-acquired and ventilator-associated bacterial pneumonia (HAP/VAP) caused by Gram negative bacterial pathogens, subject to regulatory approval by the Ministry of Health of the Russian Federation. Exblifep is a carbapenem-sparing antibiotic developed to address the growing clinical challenge posed by ESBL-producing Gram-negative bacteria in serious hospital infections. The product is approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), is included in IDSA and EUCAST treatment guidelines, and is the first new chemical entity originating from an Indian pharmaceutical company to receive both approvals. Under the agreement, Pharmasyntez will hold the exclusive rights to register and commercialize Exblifep in Russia, with Orchid supplying the finished dosage form. The partnership represents a potential opportunity of approximately USD 178 million over the first 10 years, reflecting the scale of unmet clinical need and the significant hospital procurement volumes in the Russian market.

Voltamp Transformers has fixed 24 July 2026 as record date for  the purpose of determining entitlement of the shareholders of the company to receive dividend of Rs 100/- (@1000%) per equity share having face value of Re. 10/- each fully paid-up for the financial year 2025-26.

Concord Biotech has fixed 24 July 2026 as record date for payment of final dividend for FY 2026.

Pondy Oxides & Chemicals has fixed 21 July 2026 as record date for stock split of the existing equity shares of the Company such that 2 (Two) equity shares having face value of Rs. 5 each fully paid-up be sub-divided into 5 (Five) equity shares having a face value of Rs. 2 each fully paid-up.

Oriental Hotels has fixed 23 July 2026 as record date for determining the member eligible to receive final dividend for FY 2026.

Apollo Pipes has fixed 17 July 2026 as record date for payment of final dividend of Rs 0.70 per share for FY 2026.

Sonata Software has fixed 17 July 2026 as record date for final dividend for FY 2026.